glp 1 ophthalmology GLP-1 RA Weight Loss Drugs May Carry Untold Ocular Burden GLP-1s: treating metabolism, not just
Description
Most people using these treatments are individuals who have struggled with weight their entire lives
This webinar brings together leading experts to explore evolving market dynamics, regulatory considerations, and product innovation strategies shaping the future of weight management
As studies continue, researchers say the medications are increasingly being examined not only as metabolic treatments, but also as drugs that may influence brain function, behavior and emotional regulation
The metabolic logic is straightforward: if muscle is not being used and challenged under load, and the body is in an energy deficit, that tissue becomes a target for catabolism
ApoE4: an emerging therapeutic target for Alzheimers disease
Management of poststroke hyperglycemia: results of the TEXAIS randomized clinical trial
